| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acceleration of Proteinuria without Significant Impact on Renal Function and Its Protection by Angiotensin II Receptor Blocker in Rats Treated with Axitinib
|
Imai, Satoshi
|
|
2015
|
11 |
3 |
p. 309-315
|
artikel
|
| 2 |
Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status
|
Huguet, Florence
|
|
2015
|
11 |
3 |
p. 371-381
|
artikel
|
| 3 |
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy
|
Van Cutsem, Eric
|
|
2015
|
11 |
3 |
p. 383-400
|
artikel
|
| 4 |
An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib
|
Mateo, J.
|
|
2016
|
11 |
3 |
p. 401-415
|
artikel
|
| 5 |
A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer
|
Loupakis, Fotios
|
|
2015
|
11 |
3 |
p. 293-308
|
artikel
|
| 6 |
Changes in Renal Function of Patients with Metastatic Renal Cell Carcinoma During Treatment with Molecular-Targeted Agents
|
Miyake, Hideaki
|
|
2015
|
11 |
3 |
p. 329-335
|
artikel
|
| 7 |
Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAFV600 Mutation
|
Dhillon, Sohita
|
|
2016
|
11 |
3 |
p. 417-428
|
artikel
|
| 8 |
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer
|
Pietrantonio, Filippo
|
|
2015
|
11 |
3 |
p. 337-343
|
artikel
|
| 9 |
Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy
|
Despierre, Evelyn
|
|
2016
|
11 |
3 |
p. 429
|
artikel
|
| 10 |
Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells
|
Schmohl, J. U.
|
|
2015
|
11 |
3 |
p. 353-361
|
artikel
|
| 11 |
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis
|
Massari, Francesco
|
|
2015
|
11 |
3 |
p. 345-351
|
artikel
|
| 12 |
Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer
|
Sarantopoulos, John
|
|
2015
|
11 |
3 |
p. 317-327
|
artikel
|
| 13 |
Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation Sequencing
|
Harlé, Alexandre
|
|
2015
|
11 |
3 |
p. 363-370
|
artikel
|
| 14 |
Systematic Review of the Side Effects Associated With Anti-HER2-Targeted Therapies Used in the Treatment of Breast Cancer, on Behalf of the EORTC Quality of Life Group
|
Sodergren, Samantha C.
|
|
2015
|
11 |
3 |
p. 277-292
|
artikel
|
| 15 |
Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors
|
Bohn, Jan-Paul
|
|
2016
|
11 |
3 |
p. 263-275
|
artikel
|
Tijdschrift beschrijving